ONO-2745 Phase II Study

ONO-2745 phase II study in patients undergoing a surgery under general anesthesia

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221456

Enrollment

Registered

2011-05-12

Start date

2011-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing a surgery under general anesthesia requiring opiate analgestics

Interventions

investigational material(s) Generic name etc : ONO-2745 INN of investigational material : remimazolam Therapeutic category code : 111 General anesthetics Dosage and Administration for Investigational

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 20 years or older of age 2. Inpatient 3. Patients undergoing a surgery under general anesthesia requiring opiate analgestics

Exclusion criteria

Exclusion criteria: 1. Patients undergoing a emergency surgery

Design outcomes

Primary

Measure	Time frame
Efficasy safety, and pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026